Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

9.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K
Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

9.8K
Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
9.8K
Protein-protein Interfaces02:04

Protein-protein Interfaces

14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

209
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
209
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

175
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
175
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis, in vitro and in vivo biological evaluation, and comprehensive understanding of structure-activity relationships of dipeptidyl boronic acid proteasome inhibitors constructed from β-amino acids.

Journal of medicinal chemistry·2010
Same author

Evaluation of the association between the AC3 genetic polymorphisms and obesity in a Chinese Han population.

PloS one·2010
Same author

Structure of yeast regulatory subunit: a glimpse into the evolution of PKA signaling.

Structure (London, England : 1993)·2010
Same author

[Effect of Rhizoma Coptidis coadministration with Cortex Cinnamomi on tissue distribution of berberine in rats].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2010
Same author

Exosomal-like vesicles with immune-modulatory features are present in human plasma and can induce CD4+ T-cell apoptosis in vitro.

Transfusion·2010
Same author

Qualitative analysis and simultaneous quantification of phenolic compounds in the aerial parts of Salvia miltiorrhiza by HPLC-DAD and ESI/MS(n).

Phytochemical analysis : PCA·2010

Related Experiment Video

Updated: Dec 30, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.5K

NegStacking: Drug-Target Interaction Prediction Based on Ensemble Learning and Logistic Regression.

Jie Yang, Song He, Zhongnan Zhang

    IEEE/ACM Transactions on Computational Biology and Bioinformatics
    |January 28, 2020
    PubMed
    Summary

    NegStacking, a novel stacking framework, enhances drug-target interaction (DTI) prediction by effectively utilizing negative samples. This approach improves DTI identification, crucial for accelerating drug discovery.

    More Related Videos

    Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
    08:49

    Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

    Published on: June 20, 2025

    1.0K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.5K

    Related Experiment Videos

    Last Updated: Dec 30, 2025

    Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
    10:21

    Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

    Published on: February 23, 2024

    3.5K
    Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
    08:49

    Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

    Published on: June 20, 2025

    1.0K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.5K

    Area of Science:

    • Computational biology
    • Bioinformatics
    • Machine learning in drug discovery

    Background:

    • Drug-target interactions (DTIs) are vital in drug research.
    • Predicting DTIs using machine learning often faces challenges due to imbalanced datasets (fewer positive than negative samples).
    • Existing methods inadequately leverage large negative sample sets, limiting prediction accuracy.

    Purpose of the Study:

    • To propose a stacking framework, NegStacking, to improve DTI prediction performance.
    • To address the insufficient utilization of negative samples in DTI prediction models.
    • To enhance the efficiency of the drug discovery process through better DTI identification.

    Main Methods:

    • Developed a stacking framework (NegStacking) for DTI prediction.
    • Employed sampling to generate diverse negative sample sets.
    • Trained weak learners on different negative and common positive sample sets.
    • Utilized logistic regression (LR) as a meta-learner for adaptive combination.
    • Incorporated feature subspacing and hyperparameter perturbation to boost ensemble diversity.

    Main Results:

    • NegStacking demonstrated superior performance compared to existing DTI prediction methods.
    • The framework effectively improves the prediction of drug-target interactions.
    • Experimental results validate the model's effectiveness and potential.

    Conclusions:

    • NegStacking offers a significant advancement in DTI prediction by addressing data imbalance.
    • The proposed method shows broad application prospects for accelerating drug discovery.
    • The source code and datasets are publicly available for further research and development.